Closed loop neural stimulation synchronized to cardiac cycles

• US 8,406,876 B2
• Filed: 01/15/2010
• Issued: 03/26/2013
• Est. Priority Date: 04/05/2005
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: McCabe, Aaron R., Libbus, Imad, Zhang, Yi, Haefner, Paul A., Sathaye, Alok S., Caparso, Anthony V., Brooke, M. Jason
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US12/688,575
• Publication Number:
  US 20100121399A1
• Time in Patent Office: 1,166 Days
• Field of Search: 607 1- 2, 607 4- 7, 607/9, 607/11, 607 14- 15, 607 27- 28, 607/115, 607/116, 607/119
• US Class Current: 607/14
• CPC Class Codes: A61N 1/36053 adapted for vagal stimulation A61N1/36114 takes precedence
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36128 Control systems
• CPC Class Codes: A61N 1/36139 with automatic adjustment

Abstract

Various aspects of the present subject matter relate to a method. According to various method embodiments, cardiac activity is detected, and neural stimulation is synchronized with a reference event in the detected cardiac activity. Neural stimulation is titrated based on a detected response to the neural stimulation. Other aspects and embodiments are provided herein.

Claims

1. A method for treating a patient, comprising:

stimulating a baroreflex system of the patient with a baroreflex activation device according to a baroreflex activation therapy (“

BAT”

);

detecting a pacing pulse generated from a cardiac management device (“

CRM”

) device by the baroreflex activation device; and

adjusting the baroreflex activation therapy in response to the detected pacing pulse.

2. The method of claim 1, wherein the baroreflex activation device is connectable to an output terminal of the CRM device.

3. The method of claim 1, wherein the baroreflex activation device adjusts the timing of at least one baroreflex stimulation pulse based on detection of the detected pacing pulse.

4. The method of claim 3, wherein the baroreflex activation device comprises a pulse generator for providing at least one baroreflex stimulation pulse.

5. The method of claim 3, wherein adjusting the BAT comprises changing one or more characteristics of pulses generated by the baroreflex activation device.

6. The method of claim 5, wherein the characteristics of the pulse generated by the baroreflex activation device includes any one or more of pulse amplitude, frequency, burst energy, and wave characteristics.

7. The method of claim 1, wherein the BAT is delivered at a pre-selected time after detecting pacing pulses generated by the CRM device.

8. The method of claim 1, wherein the stimulation comprises stimulating a nerve or receptor.

9. The method of claim 8, wherein the nerve or receptor is a baroreceptor or a nerve leading from a baroreceptor.

10. The method of claim 1, wherein the intensity of the BAT is adjusted in response to the frequency of the detected pacing pulse.

11. The method of claim 1, wherein the BAT is performed in multiple steps.

12. The method of claim 1, wherein there is a pre-determined time delay between applying the multiple steps of the BAT.

13. The method of claim 1, wherein the BAT is delivered during systole or diastole cardiac phases.

14. The method of claim 7, wherein stimulating a baroreflex system includes delivering stimulation bursts with multiple burst durations and burst interval sequences, and wherein adjusting the baroreflex activation therapy includes adjusting the delivery of neural stimulation pulses based on heart rate.

15. The method of claim 1, wherein the baroreflex activation device and the CRM device are implantable within the patient.

16. The method of claim 15, wherein the baroreflex activation device and the CRM device are combined in a single housing.

17. The method of claim 15, wherein the baroreflex activation device and the CRM device are each housed in a separate housing.

18. The method of claim 1, wherein the pacing pulse generated by the CRM device is responsive to at least one or more of heart rate, cardiac waveform, timing of arterial and/or ventricular contractions, venous or arterial pressure, venous or arterial volume, cardiac output, pressure and/or volume in one or more heart chambers, cardiac efficiency, cardiac impedance, and edema.

19. The method of claim 1, wherein the method further comprises treatment of hypertension as well as resynchronization of the patient'"'"'s heart.

20. The method of claim 1, wherein the method further comprises treatment of hypertension cardiac arrhythmia.